Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) went up by 7.00% from its latest closing price when compared to the 1-year high value of $7.67 and move down -100.79%, while CPRX stocks collected +39.42% of gains with the last five trading sessions. Press Release reported on 03/16/20 that Catalyst Pharmaceuticals Reports Fourth Quarter and Year-End 2019 Financial Results and Provides Corporate Update
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Worth an Investment?
Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) scored price to earnings ratio above its average ratio, recording 12.78 times of increase in earnings at the present.
CPRX Market Performance
CPRX stocks went up by 39.42% for the week, with the monthly drop of -15.67% and a quarterly performance of -1.04%, while its annual performance rate touched -24.51%. The simple moving average for the period of the last 20 days is 6.30% for CPRX stocks with the simple moving average of -17.92% for the last 200 days.
Analysts’ Opinion on Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)
Many brokerage firms have already submitted their reports for CPRX stocks, with Cantor Fitzgerald repeating the rating for CPRX shares by setting it to “Overweight”. The predicted price for CPRX socks in the upcoming period according to Cantor Fitzgerald is $40 based on the research report published on September 21, 2018.
Piper Jaffray, on the other hand, stated in their research note that they expect to see CPRX stock at the price of $40. The rating they have provided for CPRX stocks is “Overweight” according to the report published on September 7, 2018.
Piper Jaffray gave “ Overweight” rating to CPRX stocks, setting the target price at $40 in the report published on October 5, 2016.
CPRX Stocks -7.29% Far from 50 Day Moving Average
After a stumble in the market that brought CPRX to its low price for the period of the last 52 weeks, Catalyst Pharmaceuticals, Inc. was unable to take a rebound, for now settling with -50.20% of loss for the given period.
The stock volatility was left at 13.89%, however, within the period of a single month, the volatility rate increased by 13.45%, while the shares sank at the distance of -18.03% for the moving average in the last 20 days. In oppose to the moving average for the last 50 days, trading by -9.91% lower at the present time.
In the course of the last 5 trading sessions, CPRX went up by +39.42%, which changed the moving average for the period of 200 days to the total of +16.82% of gains for the stock in comparison to the 20-day moving average settled at $3.55. In addition, Catalyst Pharmaceuticals, Inc. saw 1.87% in overturn over the period of a single year with a tendency to cut further gains.
CPRX Stock Insider Trading
Reports are indicating that there were more than several insider trading activities at Catalyst Pharmaceuticals, Inc. (CPRX), starting from INGENITO GARY, who sold 150,000 shares at the price of $4.82 back on Dec 05. After this action, Rushing now owns 0 shares of Catalyst Pharmaceuticals, Inc., valued at $723,150 with the latest closing price.
INGENITO GARY, the Chief Medical Officer of Catalyst Pharmaceuticals, Inc., sold 100,000 shares at the value of $4.66 during a trade that took place back on Nov 27, which means that INGENITO GARY is holding 0 shares at the value of $466,000 based on the most recent closing price.
CPRX Stock Fundamentals
The current profitability levels are settled at +31.11 for the present operating margin and +85.57 for gross margin. The net margin for Catalyst Pharmaceuticals, Inc. stands at +31.16. Equity return holds the value 45.50%, with 36.60% for asset returns.